Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation

Transplant Infectious Disease

Volumn 11, Issue 1, 2009, Pages 20-27

  Cummins, N W ^b,c   Deziel, P J ^c   Abraham, R S ^a   Razonable, R R ^a,b,c  

^a Mayo Clinic   (United States)

^b Division of Infectious Diseases   (United States)

^c William J von Liebig Transplant Center   (United States)

Author keywords

CD8+; Cytomegalovirus; Immunity; Kidney transplantation; Late onset; Outcome; T cells

Indexed keywords

COTRIMOXAZOLE; CYCLOSPORIN; GAMMA INTERFERON; GANCICLOVIR; IONOMYCIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHORBOL 13 ACETATE 12 MYRISTATE; RITUXIMAB; VALGANCICLOVIR;

ADULT; AGED; ARTICLE; CASE REPORT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COLITIS; COLON BIOPSY; CYTOMEGALOVIRUS INFECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOCOMPETENCE; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNITY, CELLULAR; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MALE; PANCREAS TRANSPLANTATION; TIME FACTORS;

EID: 58649103988     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2008.00344.x     Document Type: Article

References (16)

1. Razonable RR. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am J Health Syst Pharm 2005 62 (Suppl 1 S7 S13.
2. Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant 2007 12 : 610 617.
3. Legendre C, Pascual M. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin Infect Dis 2008 46 : 732 740.
4. Kijpittayarit-Arthurs S, Eid AJ, Kremers WK, et al. Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients. J Heart Lung Transplant 2007 26 : 1019 1024.
5. Arthurs SK, Eid AJ, Pedersen RA, et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl 2007 13 : 1703 1709.
6. Arthurs SK, Eid AJ, Pedersen RA, et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008 46 : 840 846.
7. Shibolet O, Ilan Y, Kalish Y, et al. Late cytomegalovirus disease following liver transplantation. Transpl Int 2003 16 : 861 865.
8. Slifkin M, Tempesti P, Poutsiaka DD, Snydman DR. Late and atypical cytomegalovirus disease in solid-organ transplant recipients. Clin Infect Dis 2001 33 : E62 E68.
9. Shibolet O, Ilan Y, Kalish Y, et al. Late cytomegalovirus infection occurring two or more years following liver transplantation: a report of seven cases and review of the literature. Transplant Proc 2003 35 : 663 664.
10. Kijpittayarit S, Deziel P, Eid AJ, Razonable RR. Primary cytomegalovirus disease after five years of antiviral prophylaxis. Transplantation 2006 81 : 137 138.
11. Humar A, Mazzulli T, Moussa G, et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant 2005 5 : 1065 1070.
12. Razonable RR, Rivero A, Rodriguez A, et al. Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir. J Infect Dis 2001 184 : 1461 1464.
13. Limaye AP, Bakthavatsalam R, Kim HW, et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 2004 78 : 1390 1396.
14. Eid AJ, Arthurs SK, Deziel PJ, Wilhelm MP, Razonable RR. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes. Clin Transplant 2008 22 : 162 170.
15. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 2003 101 : 407 414.
16. Boeckh M, Riddell SR. Immunologic predictors of late cytomegalovirus disease after solid organ transplantation - an elusive goal? J Infect Dis 2007 195 : 615 617.